We are live on ! Find out more
AHG

Akso Health Group

5 hedge funds and large institutions have $145K invested in Akso Health Group in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.46% less ownership

Funds ownership: 2.07% → 1.61% (-0.46%)

29% less funds holding

Funds holding: 7 → 5 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

68% less capital invested

Capital invested by funds: $448K → $145K (-$303K)

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AHG Hedge Fund Activity: Q4 2022 in Review

5 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2022, worth a combined $145K — down 68% from $448K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AHG and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $7.34K. The largest seller was Renaissance Technologies, cutting an estimated $39.2K.

  • 5 institutional investors held Akso Health Group (AHG) as of Q4 2022, down from 7 in Q3 2022.
  • Funds reported $145K of Akso Health Group stock for Q4 2022, down 68% quarter-over-quarter.
  • 1 fund opened new Akso Health Group positions in Q4 2022 and 3 closed out, a net change of -2 holders.
  • The largest Akso Health Group buyer in Q4 2022 was Two Sigma Securities, an estimated $7.34K added.
  • The largest Akso Health Group seller in Q4 2022 was Renaissance Technologies, an estimated $39.2K sold.

Based on aggregated 13F filings for Q4 2022.